EG19303A - Process for preparing of new therapeutically active compound - Google Patents

Process for preparing of new therapeutically active compound

Info

Publication number
EG19303A
EG19303A EG62189A EG62189A EG19303A EG 19303 A EG19303 A EG 19303A EG 62189 A EG62189 A EG 62189A EG 62189 A EG62189 A EG 62189A EG 19303 A EG19303 A EG 19303A
Authority
EG
Egypt
Prior art keywords
preparing
active compound
therapeutically active
new therapeutically
new
Prior art date
Application number
EG62189A
Other languages
English (en)
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haessle Ab filed Critical Haessle Ab
Application granted granted Critical
Publication of EG19303A publication Critical patent/EG19303A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/28—Sulfur atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EG62189A 1988-12-22 1989-12-18 Process for preparing of new therapeutically active compound EG19303A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE19888804629A SE8804629D0 (sv) 1988-12-22 1988-12-22 New therapeutically active compounds

Publications (1)

Publication Number Publication Date
EG19303A true EG19303A (en) 1994-11-30

Family

ID=20374310

Family Applications (1)

Application Number Title Priority Date Filing Date
EG62189A EG19303A (en) 1988-12-22 1989-12-18 Process for preparing of new therapeutically active compound

Country Status (32)

Country Link
US (2) US5008278A (zh)
EP (1) EP0449940B1 (zh)
JP (1) JP2793906B2 (zh)
KR (1) KR910700249A (zh)
CN (1) CN1028231C (zh)
AR (1) AR248136A1 (zh)
AT (1) ATE127799T1 (zh)
AU (1) AU634741B2 (zh)
BG (1) BG60102B2 (zh)
CA (1) CA2005986C (zh)
DD (2) DD296079A5 (zh)
DE (1) DE68924273T2 (zh)
DK (1) DK170800B1 (zh)
EG (1) EG19303A (zh)
FI (2) FI913035A0 (zh)
GR (1) GR1002252B (zh)
HR (1) HRP920831A2 (zh)
HU (2) HU205927B (zh)
IE (1) IE894048L (zh)
IL (1) IL92798A0 (zh)
LT (2) LT3980B (zh)
LV (1) LV10187B (zh)
NZ (1) NZ231872A (zh)
PH (1) PH27400A (zh)
PL (1) PL161150B1 (zh)
PT (1) PT92648B (zh)
RO (1) RO110494B1 (zh)
RU (2) RU2073676C1 (zh)
SE (1) SE8804629D0 (zh)
WO (1) WO1990006925A1 (zh)
YU (1) YU46806B (zh)
ZA (2) ZA899794B (zh)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993006097A1 (en) * 1991-09-20 1993-04-01 Merck & Co., Inc. Novel process for the preparation of anti-ulcer agents
TNSN95063A1 (fr) * 1994-05-27 1996-02-06 Astra Ab Nouveaux benzimidazoles substitues
SE9402431D0 (sv) * 1994-07-08 1994-07-08 Astra Ab New tablet formulation
DE29522419U1 (de) * 1994-07-08 2003-07-03 AstraZeneca AB, Södertälje Tablettierte Mehrfacheinheits-Dosisform
SE9500422D0 (sv) * 1995-02-06 1995-02-06 Astra Ab New oral pharmaceutical dosage forms
SE9500478D0 (sv) * 1995-02-09 1995-02-09 Astra Ab New pharmaceutical formulation and process
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6699885B2 (en) * 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US6645988B2 (en) * 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
SE9600070D0 (sv) 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
DE19758573C2 (de) * 1997-11-26 2001-03-01 Implex Hear Tech Ag Fixationselement für ein implantierbares Mikrofon
ES2373864T3 (es) * 1998-04-20 2012-02-09 Eisai R&D Management Co., Ltd. Composición estabilizada que contiene un compuesto de tipo bencimidazol.
TWI243672B (en) 1999-06-01 2005-11-21 Astrazeneca Ab New use of compounds as antibacterial agents
US7220762B1 (en) 1999-10-20 2007-05-22 Eisai R&D Management Co., Ltd. Methods for stabilizing benzimidazole compounds
SE0000774D0 (sv) 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
SE0101379D0 (sv) 2001-04-18 2001-04-18 Diabact Ab Komposition som hämmar utsöndring av magsyra
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
SE0102993D0 (sv) 2001-09-07 2001-09-07 Astrazeneca Ab New self emulsifying drug delivery system
MXPA04007169A (es) * 2002-01-25 2004-10-29 Santarus Inc Suministro transmucosal de inhibidores de bomba de protones.
US20050234103A1 (en) * 2002-03-26 2005-10-20 Reddy Manne S Crystalline forms of rabeprazole sodium
SE0203065D0 (sv) 2002-10-16 2002-10-16 Diabact Ab Gastric acid secretion inhibiting composition
JP2006518751A (ja) * 2003-02-20 2006-08-17 サンタラス インコーポレイティッド 胃酸の急速かつ持続的な抑制のための新規製剤、オメプラゾール制酸剤複合体−即時放出物
TWI398273B (zh) * 2003-07-18 2013-06-11 Santarus Inc 用於抑制酸分泌之醫藥調配物及其製備及使用之方法
US8993599B2 (en) * 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
TWI337877B (en) * 2003-07-18 2011-03-01 Santarus Inc Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders
ATE544447T1 (de) 2003-09-26 2012-02-15 Alza Corp Arzneistoffcoating mit hohem wirkstoffanteil sowie methoden zu dessen herstellung
US20070292498A1 (en) * 2003-11-05 2007-12-20 Warren Hall Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
US8815916B2 (en) * 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) * 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8541026B2 (en) 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
US7803817B2 (en) 2005-05-11 2010-09-28 Vecta, Ltd. Composition and methods for inhibiting gastric acid secretion
US7981908B2 (en) 2005-05-11 2011-07-19 Vecta, Ltd. Compositions and methods for inhibiting gastric acid secretion
WO2008012621A2 (en) 2006-07-25 2008-01-31 Vecta, Ltd. Compositions and meth0ds for inhibiting gastric acide secretion using derivatives of small dicarboxylic acids in combination with ppi
US20090092658A1 (en) * 2007-10-05 2009-04-09 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
JP2012502015A (ja) 2008-09-09 2012-01-26 アストラゼネカ・アクチエボラーグ 必要がある患者に医薬組成物を送達するための方法
KR20120030106A (ko) 2009-06-25 2012-03-27 아스트라제네카 아베 Ｎｓａｉｄ-연관된 궤양의 발생 위험이 있는 환자의 치료 방법
WO2011080500A2 (en) 2009-12-29 2011-07-07 Orexo Ab New pharmaceutical dosage form for the treatment of gastric acid-related disorders
WO2011080502A2 (en) 2009-12-29 2011-07-07 Orexo Ab New pharmaceutical dosage form for the treatment of gastric acid-related disorders
WO2011080501A2 (en) 2009-12-29 2011-07-07 Orexo Ab New pharmaceutical dosage form for the treatment of gastric acid-related disorders
EP2601947A1 (en) 2011-12-05 2013-06-12 Abo Bakr Mohammed Ali Al-Mehdar Fixed-dose combination for treatment of helicobacter pylori associated diseases
CN104519888A (zh) 2011-12-28 2015-04-15 波曾公司 用于递送奥美拉唑和乙酰水杨酸的改良组合物和方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US428098A (en) 1890-05-20 Electric railway
US727150A (en) 1902-06-18 1903-05-05 Peter Paul Keller Adjustable hanger for incandescent lamps.
SE418966B (sv) * 1974-02-18 1981-07-06 Haessle Ab Analogiforfarande for framstellning av foreningar med magsyrasekretionsinhiberande verkan
SE416649B (sv) * 1974-05-16 1981-01-26 Haessle Ab Forfarande for framstellning av foreningar som paverkar magsyrasekretionen
IN148930B (zh) * 1977-09-19 1981-07-25 Hoffmann La Roche
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
US4359465A (en) * 1980-07-28 1982-11-16 The Upjohn Company Methods for treating gastrointestinal inflammation
CH644116A5 (de) * 1980-08-21 1984-07-13 Hoffmann La Roche Imidazolderivate.
DE3215503A1 (de) 1982-04-26 1983-11-03 Zängl GmbH, 8000 München Elektrisch beheiztes schneidgeraet
SE8301182D0 (sv) * 1983-03-04 1983-03-04 Haessle Ab Novel compounds
IL71664A (en) * 1983-05-03 1987-11-30 Byk Gulden Lomberg Chem Fab Fluoroalkoxy compounds,process for their preparation and pharmaceutical compositions containing the same
JPS6150978A (ja) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
JPS6150979A (ja) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
AU568441B2 (en) * 1984-09-24 1987-12-24 Upjohn Company, The 2-(pyridylalkenesulfinyl) benzimidazole derivatives
US4738975A (en) * 1985-07-02 1988-04-19 Takeda Chemical Industries, Ltd. Pyridine derivatives, and use as anti-ulcer agents
JPS6261978A (ja) * 1985-09-12 1987-03-18 Otsuka Pharmaceut Co Ltd ５−フルオロ−１ｈ−ベンズイミダゾ−ル誘導体
SE8505112D0 (sv) * 1985-10-29 1985-10-29 Haessle Ab Novel pharmacological compounds
JPS62201884A (ja) * 1986-02-28 1987-09-05 Tokyo Tanabe Co Ltd ベンズイミダゾール誘導体及びその製造法
FI90544C (fi) * 1986-11-13 1994-02-25 Eisai Co Ltd Menetelmä lääkeaineina käyttökelpoisten 2-pyridin-2-yyli-metyylitio- ja sulfinyyli-1H-bensimidatsolijohdannaisten valmistamiseksi
NZ222495A (en) * 1986-11-21 1991-04-26 Haessle Ab Benzimidazole derivatives and pharmaceutical compositions
FI96860C (fi) * 1987-06-17 1996-09-10 Eisai Co Ltd Analogiamenetelmä lääkeaineena käytettävän pyridiinijohdannaisen valmistamiseksi
DE3722810A1 (de) * 1987-07-10 1989-01-19 Hoechst Ag Substituierte benzimidazole, verfahren zu deren herstellung, diese enthaltende pharmazeutische zubereitungen und deren verwendung
DK171989B1 (da) * 1987-08-04 1997-09-08 Takeda Chemical Industries Ltd Fremgangsmåde til fremstilling af 2-(2-pyridylmethylsulfinyl)-benzimidazoler
JPH0676323B2 (ja) * 1987-08-28 1994-09-28 東京田辺製薬株式会社 抗潰瘍剤

Also Published As

Publication number Publication date
RU2073676C1 (ru) 1997-02-20
ZA899794B (en) 1990-08-29
HRP920831A2 (en) 1995-12-31
HU901084D0 (en) 1991-09-30
DK122291D0 (da) 1991-06-21
IE894048L (en) 1990-06-22
CA2005986C (en) 1999-08-03
CN1043713A (zh) 1990-07-11
ATE127799T1 (de) 1995-09-15
JP2793906B2 (ja) 1998-09-03
JPH04502461A (ja) 1992-05-07
DD296079A5 (de) 1991-11-21
US5039808A (en) 1991-08-13
LT3980B (en) 1996-06-25
DK122291A (da) 1991-06-24
NZ231872A (en) 1992-03-26
DD296078A5 (de) 1991-11-21
HU205926B (en) 1992-07-28
SE8804629D0 (sv) 1988-12-22
LTIP1726A (en) 1995-07-25
AR248136A1 (es) 1995-06-30
DK170800B1 (da) 1996-01-22
HUT57202A (en) 1991-11-28
KR910700249A (ko) 1991-03-14
IL92798A0 (en) 1990-09-17
LT3914B (en) 1996-04-25
PH27400A (en) 1993-06-21
YU46806B (sh) 1994-06-10
LV10187A (lv) 1994-10-20
WO1990006925A1 (en) 1990-06-28
CA2005986A1 (en) 1990-06-22
AU634741B2 (en) 1993-03-04
BG60102B2 (bg) 1993-10-29
EP0449940B1 (en) 1995-09-13
CN1028231C (zh) 1995-04-19
FI913035A0 (fi) 1991-06-20
LV10187B (en) 1995-04-20
ZA899795B (en) 1990-08-29
PT92648B (pt) 1995-09-12
FI954768A (fi) 1995-10-06
FI954768A0 (fi) 1995-10-06
RO110494B1 (ro) 1996-01-30
DE68924273T2 (de) 1996-02-15
LTIP1721A (en) 1995-07-25
YU242689A (en) 1991-04-30
GR890100838A (el) 1991-03-15
PL161150B1 (en) 1993-05-31
DE68924273D1 (de) 1995-10-19
PT92648A (pt) 1990-06-29
AU4817590A (en) 1990-07-10
US5008278A (en) 1991-04-16
EP0449940A1 (en) 1991-10-09
HU205927B (en) 1992-07-28
RU2042673C1 (ru) 1995-08-27
GR1002252B (en) 1996-04-23

Similar Documents

Publication Publication Date Title
EG19303A (en) Process for preparing of new therapeutically active compound
EG18398A (en) Process for preparing of piperazinyl-heterocyclic compounds
GB8813484D0 (en) Process for preparation of oxirane compound
HU891461D0 (en) Process for the preparation of novel compounds
MW388A1 (en) Process for the preparation of thiazepine compound
NO175978C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive bis-aza-bicykliske forbindelser
NO178619C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive di-t-butylfenoler
YU20288A (en) Process for preparing derivatives of adenosyn 5-carboxamides
HU891463D0 (en) Process for the preparation of novel compounds
HU896774D0 (en) Process for preparation of condensated-quinoline-derivatives
NO174959C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive N-aminobutyl-N-fenyl-arylamidderivater
HU896728D0 (en) Process for preparation of mono-n-alkylated polyzamacrocyclides
HUT50758A (en) Process for production of optically active naftotiasepinons
YU125389A (en) Process for preparing derivatives of tricyclical 3-oxo-propan-nitryl
NO174200C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-imino-6-polyfluoralkoksybenzotiazol-forbindelser
GB8819224D0 (en) Process for preparation of rod-like compounds
HUT58337A (en) Process for producing pharmaceutically active benzopyranopyrazols
DE3570650D1 (en) Process for the preparation of optically active derivatives of hydroquinone
YU76584A (en) Process for making pharmaceutically active derivatives of pyridazine
ZA875174B (en) A method for the preparation of a therapeutically active compound
YU46788A (en) Process for preparing optical active derivatives of osco-izoindolinyl
NO179367C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive fenoksy-heterocykliske forbindelser
HUT40630A (en) Process for producing relative compounds of histarigin and pharmaceutical compounds containing them as active agents
EG19360A (en) Process for preparing of therapeutically active fluro substituted benzimidazoles
HU896683D0 (en) Process for the preparation of new therapeutical preparations